167 related articles for article (PubMed ID: 33772663)
1. Discrepancies in metabolomic biomarker identification from patient-derived lung cancer revealed by combined variation in data pre-treatment and imputation methods.
Miller HA; Emam R; Lynch CM; Bockhorst S; Frieboes HB
Metabolomics; 2021 Mar; 17(4):37. PubMed ID: 33772663
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data.
Miller HA; van Berkel VH; Frieboes HB
Metabolomics; 2022 Jul; 18(8):57. PubMed ID: 35857204
[TBL] [Abstract][Full Text] [Related]
3. Two data pre-processing workflows to facilitate the discovery of biomarkers by 2D NMR metabolomics.
Féraud B; Leenders J; Martineau E; Giraudeau P; Govaerts B; de Tullio P
Metabolomics; 2019 Apr; 15(4):63. PubMed ID: 30993405
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Machine Learning Methods of Analyzing Multiclass Metabolomics.
Gong Y; Ding W; Wang P; Wu Q; Yao X; Yang Q
J Chem Inf Model; 2023 Dec; 63(24):7628-7641. PubMed ID: 38079572
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic profiling of human lung tumor tissues - nucleotide metabolism as a candidate for therapeutic interventions and biomarkers.
Moreno P; Jiménez-Jiménez C; Garrido-Rodríguez M; Calderón-Santiago M; Molina S; Lara-Chica M; Priego-Capote F; Salvatierra Á; Muñoz E; Calzado MA
Mol Oncol; 2018 Oct; 12(10):1778-1796. PubMed ID: 30099851
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Biomarker Identification in Presence of Outliers and Missing Values.
Kumar N; Hoque MA; Shahjaman M; Islam SM; Mollah MN
Biomed Res Int; 2017; 2017():2437608. PubMed ID: 28293630
[TBL] [Abstract][Full Text] [Related]
8. GSimp: A Gibbs sampler based left-censored missing value imputation approach for metabolomics studies.
Wei R; Wang J; Jia E; Chen T; Ni Y; Jia W
PLoS Comput Biol; 2018 Jan; 14(1):e1005973. PubMed ID: 29385130
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
10. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics workflow for lung cancer: Discovery of biomarkers.
Tang Y; Li Z; Lazar L; Fang Z; Tang C; Zhao J
Clin Chim Acta; 2019 Aug; 495():436-445. PubMed ID: 31103622
[TBL] [Abstract][Full Text] [Related]
12. Statistics and Machine Learning in Mass Spectrometry-Based Metabolomics Analysis.
Fan S; Wilson CM; Fridley BL; Li Q
Methods Mol Biol; 2023; 2629():247-269. PubMed ID: 36929081
[TBL] [Abstract][Full Text] [Related]
13. Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling.
Di Guida R; Engel J; Allwood JW; Weber RJ; Jones MR; Sommer U; Viant MR; Dunn WB
Metabolomics; 2016; 12():93. PubMed ID: 27123000
[TBL] [Abstract][Full Text] [Related]
14. Missing data imputation via the expectation-maximization algorithm can improve principal component analysis aimed at deriving biomarker profiles and dietary patterns.
Malan L; Smuts CM; Baumgartner J; Ricci C
Nutr Res; 2020 Mar; 75():67-76. PubMed ID: 32035304
[TBL] [Abstract][Full Text] [Related]
15. Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets.
Alcazar O; Ogihara M; Ren G; Buchwald P; Abdulreda MH
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291653
[TBL] [Abstract][Full Text] [Related]
16. Characterization of missing values in untargeted MS-based metabolomics data and evaluation of missing data handling strategies.
Do KT; Wahl S; Raffler J; Molnos S; Laimighofer M; Adamski J; Suhre K; Strauch K; Peters A; Gieger C; Langenberg C; Stewart ID; Theis FJ; Grallert H; Kastenmüller G; Krumsiek J
Metabolomics; 2018 Sep; 14(10):128. PubMed ID: 30830398
[TBL] [Abstract][Full Text] [Related]
17. Missing value imputation strategies for metabolomics data.
Armitage EG; Godzien J; Alonso-Herranz V; López-Gonzálvez Á; Barbas C
Electrophoresis; 2015 Dec; 36(24):3050-60. PubMed ID: 26376450
[TBL] [Abstract][Full Text] [Related]
18. Random forest-based imputation outperforms other methods for imputing LC-MS metabolomics data: a comparative study.
Kokla M; Virtanen J; Kolehmainen M; Paananen J; Hanhineva K
BMC Bioinformatics; 2019 Oct; 20(1):492. PubMed ID: 31601178
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-aware imputation: a two-step approach in handling missing values in metabolomics.
Dekermanjian JP; Shaddox E; Nandy D; Ghosh D; Kechris K
BMC Bioinformatics; 2022 May; 23(1):179. PubMed ID: 35578165
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
